The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Review of Osteosarcoma and Current Management
Open accessAbstract
Osteosarcoma is the most common primary malignancy of bone in children and young adults. This tumor has a very heterogeneous genetic profile and lacks any consistent unifying event that leads to the pathogenesis of osteosarcoma. In this review, some of the important genetic events involved in osteosarcoma will be highlighted. Additionally, the clinical diagnosis of osteosarcoma will be discussed, as well as contemporary chemotherapeutic and surgical management of this tumor. Finally, the review will discuss some of the novel approaches to treating this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393 · cited 1×
“Other poor predictors of survival are increased tumor size, increased serum alkaline phosphatase, axial location, and secondary OS [102].”
BackgroundMirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., & Sporn, M. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32345-7 · Cited by 1,598
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Isakoff, M. S., Bielack, S. S., Meltzer, P., & Gorlick, R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4895 · Cited by 1,567
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345 · cited 1×
“Loss of this tumor suppressor function predisposes to a multitude of malignancies, and an estimated 30% of patients with LFS develop OS during their lives [15, 16].”
BackgroundTranslational biology of osteosarcoma
Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294 · cited 2×
“In a preclinical study, zoledronate successfully suppressed tumor growth and lung metastasis in a mouse model and is now the subject of an ongoing trial with combination chemotherapy [126, 133].”
BackgroundLink, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,204
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e · Cited by 1,090
Outcomes for children and adolescents with cancer: challenges for the twenty-first century
Smith, M. A., Seibel, N. L., Altekruse, S. F., Ries, L. A. G., Melbert, D. L., O'Leary, M., Smith, F. O., & Reaman, G. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0421 · Cited by 1,026 · cited 1×
“survival drops to 20–30% for those with metastatic disease [66, 78, 92, 101, 122].”
BackgroundKager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Nevins, J. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.699 · Cited by 922
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24320 · Cited by 791
The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*
MANKIN, H. J., MANKIN, C. J., & SIMON, M. A. (1996) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199605000-00004 · Cited by 773
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Bougeard, G., Renaux-Petel, M., Flaman, J.-M., Charbonnier, C., Fermey, P., Belotti, M., Gauthier-Villars, M., Stoppa-Lyonnet, D., Consolino, E., Brugières, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5728 · Cited by 760
The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
Goodrich, D. W., Wang, N. P., Qian, Y.-W., Lee, E. Y.-H. P., & Lee, W.-H. (1991) · Cell · doi:10.1016/0092-8674(91)90181-w · Cited by 707
Src kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700
Kempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643 · cited 1×
“If the recurrence can be completely surgically removed, the patient has a greatly increased chance of survival [121].”
BackgroundPrimary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., De Paolis, M., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 631
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569 · cited 1×
“TP53 encodes for p53, a master transcription factor regulating expression of DNA repair genes and initiating apoptosis when damage is irreparable [14].”
BackgroundBacci, G., Longhi, A., Versari, M., Mercuri, M., Briccoli, A., & Picci, P. (2006) · Cancer · doi:10.1002/cncr.21724 · Cited by 569
Rougraff, B. T., Simon, M. A., Kneisl, J. S., Greenberg, D. B., & Mankin, H. J. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199405000-00004 · Cited by 536
Osteosarcoma, Chondrosarcoma, and Ewing's Sarcoma: National Cancer Data Base Report
Damron, T. A., Ward, W. G., & Stewart, A. (2007) · Clinical Orthopaedics & Related Research · doi:10.1097/blo.0b013e318059b8c9 · Cited by 530
Dorfman, H. D., & Czerniak, B. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v · Cited by 496
Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur.
Simon, M. A., Aschliman, M. A., Thomas, N., & Mankin, H. J. (1986) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198668090-00005 · Cited by 469
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
Anninga, J. K., Gelderblom, H., Fiocco, M., Kroep, J. R., Taminiau, A. H. M., Hogendoorn, P. C. W., & Egeler, R. M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.030 · Cited by 456
Limb-Salvage Treatment Versus Amputation for Osteosarcoma of the Distal End of the Femur
Simon, M. A., Aschliman, M. A., Thomas, N., & Mankin, H. J. (2005) · The Journal of Bone & Joint Surgery · doi:10.2106/jbjs.8712.cl · Cited by 452
Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0734 · Cited by 422
Osteosarcoma: Anatomic and Histologic Variants
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6kqhld9lv2kenn · Cited by 386
Klein, M. J., & Siegal, G. P. (2006) · American Journal of Clinical Pathology · doi:10.1309/uc6k-qhld-9lv2-kenn · Cited by 367
Grignani, G., Palmerini, E., Dileo, P., Asaftei, S. D., D’Ambrosio, L., Pignochino, Y., Mercuri, M., Picci, P., Fagioli, F., Casali, P. G., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr151 · Cited by 359
Moore, D. D., & Luu, H. H. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-319-07323-1_4 · Cited by 349
Self-citationOsteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
Ozaki, T., Flege, S., Kevric, M., Lindner, N., Maas, R., Delling, G., Schwarz, R., von Hochstetter, A. R., Salzer-Kuntschik, M., Berdel, W. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.142 · Cited by 342
Grignani, G., Palmerini, E., Ferraresi, V., D'Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71136-2 · Cited by 340
Whelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu526 · Cited by 333
Incidence of second primary tumours among childhood cancer survivors
Hawkins, M., Draper, G., & Kingston, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.200 · Cited by 332
Radiotherapy for local control of osteosarcoma
DeLaney, T. F., Park, L., Goldberg, S. I., Hug, E. B., Liebsch, N. J., Munzenrider, J. E., & Suit, H. D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.051 · Cited by 306
Recent advances in the chemotherapy of metastatic osteogenic sarcoma
Jaffe, N. (1972) · Cancer · doi:10.1002/1097-0142(197212)30:6<1627::aid-cncr2820300631>3.0.co;2-h · Cited by 273
Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., & Yamamuro, T. (1994) · PubMed · Cited by 250
Chou, A. J., Kleinerman, E. S., Krailo, M. D., Chen, Z., Betcher, D. L., Healey, J. H., Conrad, E. U., Nieder, M. L., Weiner, M. A., Wells, R. J., et al. (2009) · Cancer · doi:10.1002/cncr.24566 · Cited by 245
Surgical options for children with osteosarcoma
Grimer, R. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01734-1 · Cited by 242
Molecular mechanisms of chemoresistance in osteosarcoma (Review)
HE, H., NI, J., & HUANG, J. (2014) · Oncology Letters · doi:10.3892/ol.2014.1935 · Cited by 234
DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders
Mohaghegh, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.741 · Cited by 229
Current strategies of chemotherapy in osteosarcoma
Carrle, D., & Bielack, S. S. (2006) · International Orthopaedics · doi:10.1007/s00264-006-0192-x · Cited by 217
Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma
Toguchida, J., Ishizaki, K., Sasaki, M. S., Nakamura, Y., Ikenaga, M., Kato, M., Sugimot, M., Kotoura, Y., & Yamamuro, T. (1989) · Nature · doi:10.1038/338156a0 · Cited by 216
Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma
Wan, X., Mendoza, A., Khanna, C., & Helman, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3135 · Cited by 216
Kaste, S. C., Pratt, C. B., Cain, A. M., Jones-Wallace, D. J., & Rao, B. N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1602::aid-cncr31>3.0.co;2-r · Cited by 215
An update on chemotherapy for osteosarcoma
Ferrari, S., & Serra, M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1102226 · Cited by 213
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis
Eary, J. F., O'Sullivan, F., Powitan, Y., Chandhury, K., Vernon, C., Bruckner, J. D., & Conrad, E. U. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0859-5 · Cited by 213
Osteosarcoma in Paget's Disease of Bone
Hansen, M. F., Seton, M., & Merchant, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s211 · Cited by 212
Defending genome integrity during DNA replication: a proposed role for RecQ family helicases
Chakraverty, R. K., & Hickson, I. D. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199904)21:4<286::aid-bies4>3.0.co;2-z · Cited by 209
Osteosarcoma: The COSS Experience
Bielack, S., Jürgens, H., Jundt, G., Kevric, M., Kühne, T., Reichardt, P., Zoubek, A., Werner, M., Winkelmann, W., & Kotz, R. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_15 · Cited by 209
Bacci, G., Rocca, M., Salone, M., Balladelli, A., Ferrari, S., Palmerini, E., Forni, C., & Briccoli, A. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21140 · Cited by 203 · cited 1×
“Although lung metastasis predicts a poorer prognosis, resection of metastatic disease can still lead to remission in some cases and has been shown to improve survival [118, 119].”
BackgroundGenome-wide association study identifies two susceptibility loci for osteosarcoma
Savage, S. A., Mirabello, L., Wang, Z., Gastier-Foster, J. M., Gorlick, R., Khanna, C., Flanagan, A. M., Tirabosco, R., Andrulis, I. L., Wunder, J. S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2645 · Cited by 202
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
Feugeas, O., Guriec, N., Babin-Boilletot, A., Marcellin, L., Simon, P., Babin, S., Thyss, A., Hofman, P., Terrier, P., Kalifa, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.467 · Cited by 199
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
PosthumaDeBoer, J., Witlox, M. A., Kaspers, G. J. L., & van Royen, B. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9384-x · Cited by 194
RecQ family helicases: roles in cancer and aging
Karow, J. K., Wu, L., & Hickson, I. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00039-8 · Cited by 192
Ferrari, S., Ruggieri, P., Cefalo, G., Tamburini, A., Capanna, R., Fagioli, F., Comandone, A., Bertulli, R., Bisogno, G., Palmerini, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4420 · Cited by 192
Osteosarcoma of the limb: AMPUTATION OR LIMB SALVAGE IN PATIENTS TREATED BY NEOADJUVANT CHEMOTHERAPY
Bacci, G., Ferrari, S., Lari, S., Mercuri, M., Donati, D., Longhi, A., Forni, C., Bertoni, F., Versari, M., & Pignotti, E. (2002) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.84b1.0840088 · Cited by 191
Osteosarcoma over the age of forty
Grimer, R. J., Cannon, S. R., Taminiau, A. M., Bielack, S., Kempf-Bielack, B., Windhager, R., Dominkus, M., Saeter, G., Bauer, H., Meller, I., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00478-1 · Cited by 188
Pathologic Fracture in Osteosarcoma: Prognostic Importance and Treatment Implications
Scully, S. P., Ghert, M. A., Zurakowski, D., Thompson, R. C., & Gebhardt, M. C. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200201000-00008 · Cited by 187
Bone and Soft Tissue Tumors : Clinical Features, Imaging, Pathology and Treatment
Campanacci, M. (1999) · Medical Entomology and Zoology · Cited by 180
Phase I Study of Everolimus in Pediatric Patients With Refractory Solid Tumors
Fouladi, M., Laningham, F., Wu, J., O'Shaughnessy, M. A., Molina, K., Broniscer, A., Spunt, S. L., Luckett, I., Stewart, C. F., Houghton, P. J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4017 · Cited by 160
Houghton, P. J., Morton, C. L., Kolb, E. A., Gorlick, R., Lock, R., Carol, H., Reynolds, C. P., Maris, J. M., Keir, S. T., Billups, C. A., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21296 · Cited by 158
Parry, M., Laitinen, M., Albergo, J. I., Jeys, L. M., Carter, S. R., Gaston, C. L., Sumathi, V. P., & Grimer, R. J. (2016) · The Bone & Joint Journal · doi:10.1302/0301-620x.98b4.36583 · Cited by 152
Stature and malignant tumors of bone in childhood and adolescence
Fraumeni, J. F. (1967) · Cancer · Cited by 150
p53 and MDM2 alterations in osteosarcomas
Lonardo, F., Ueda, T., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8<1541::aid-cncr15>3.0.co;2-y · Cited by 147
Skip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
Kager, L., Zoubek, A., Kastner, U., Kempf‐Bielack, B., Potratz, J. C., Kotz, R. I., Exner, G. U., Franzius, C., Lang, S., Maas, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2978 · Cited by 139
Aponte-Tinao, L. A., Ayerza, M. A., Múscolo, L. D., & Farfalli, G. L. (2014) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-014-4028-5 · Cited by 137
Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth.
Kappel, C. C., Velez-Yanguas, M. C. C., Hirschfeld, S., & Helman, L. J. (1994) · PubMed · Cited by 127
Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma
Marulanda, G. A., Henderson, E. R., Johnson, D. A., Letson, G. D., & Cheong, D. (2008) · Cancer Control · doi:10.1177/107327480801500103 · Cited by 125
Su, Y., Wagner, E. R., Luo, Q., et al. (2011) · Oncogene · doi:10.1038/onc.2011.97 · Cited by 124
IGF‐1 receptor contributes to the malignant phenotype in human and canine osteosarcoma
MacEwen, E. G., Pastor, J., Kutzke, J., Tsan, R. Z., Kurzman, I. D., Thamm, D. H., Wilson, M., & Radinsky, R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20046 · Cited by 118
CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB Alterations
Nielsen, G. P., Burns, K. L., Rosenberg, A. E., & Louis, D. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65556-3 · Cited by 111
Periosteal osteosarcoma – a European review of outcome
Grimer, R. J., Bielack, S., Flege, S., Cannon, S. R., Foleras, G., Andreeff, I., Sokolov, T., Taminiau, A., Dominkus, M., San-Julian, M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.052 · Cited by 110
Nellissery, M. J., Padalecki, S. S., Brkanac, Z., Singer, F. R., Roodman, G. D., Unni, K. K., Leach, R. J., & Hansen, M. F. (1998) · The American Journal of Human Genetics · doi:10.1086/302019 · Cited by 110
Mirabello, L. J., Koster, R., Moriarity, B. S., Spector, L. G., Meltzer, P. S., Gary, J. M., Machiela, M. J., Pankratz, N., Panagiotou, O. A., Largaespada, D. A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0125 · Cited by 109
Tumor metabolic rates in sarcoma using FDG PET.
Eary, J. F., & Mankoff, D. A. (1998) · PubMed · Cited by 101
Moriceau, G., Ory, B., Mitrofan, L. M., Riganti, C., Blanchard, F., Brion, R., Charrier, C., Battaglia, S., Pilet, P., Denis, M. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0578 · Cited by 101
Dekutoski, M. B., Clarke, M. J., Rose, P. S., Luzzati, A., Rhines, L. D., Varga, P. P., Fisher, C. G., Chou, D., Fehlings, M. G., Reynolds, J., et al. (2016) · Journal of Neurosurgery Spine · doi:10.3171/2015.11.spine15870 · Cited by 100
Schwartz, C. L., Wexler, L. H., Krailo, M., Teot, L. A., Devidas, M., Steinherz, L. J., Goorin, A. M., Gebhardt, M. C., Healey, J. H., Sato, J. K., et al. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25753 · Cited by 99
Advances in emerging drugs for osteosarcoma
Hattinger, C. M., Fanelli, M., Tavanti, E., Vella, S., Ferrari, S. M., Picci, P., & Serra, M. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1051965 · Cited by 98
Non‐ocular cancer in patients with hereditary retinoblastoma and their relatives
Derkinderen, D. J., Koten, J. W., Nagelkerke, N. J. D., et al. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410405 · Cited by 98
Caronia, D., Patiño‐García, A., Pérez‐Martínez, A., Pita, G., Moreno, L. T., Zalacaín, M., Molina, B., Colmenero, I., Sierrasesúmaga, L., Benitez, J. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026091 · Cited by 96
Expression of transforming growth factor-? (TGF-?) isoforms in osteosarcomas
Kloen, P., Gebhardt, M. C., Pérez‐Atayde, A. R., Rosenberg, A. E., Springfield, D. S., Gold, L. I., & Mankin, H. J. (1997) · Cancer · Cited by 92
Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma Cells
Lafleur, E. A., Koshkina, N. V., Stewart, J., Jia, S.-F., Worth, L. L., Duan, X., & Kleinerman, E. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0353 · Cited by 91
Ren, H., Sun, L., Li, H., & Ye, Z. (2015) · BioMed Research International · doi:10.1155/2015/160835 · Cited by 88
Hang, J., & Chen, P. C.-H. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2013-0030-rs · Cited by 85
Sarcomas in hereditary retinoblastoma
Kleinerman, R. A., Schonfeld, S. J., & Tucker, M. A. (2012) · Clinical Sarcoma Research · doi:10.1186/2045-3329-2-15 · Cited by 79
The Current and Future Therapies for Human Osteosarcoma
Lamplot, J. D., Denduluri, S. K., Qin, J., Li, R., Liu, X., Zhang, H., Chen, X., Wang, N., Pratt, A., Shui, W., et al. (2013) · Current Cancer Therapy Reviews · doi:10.2174/1573394711309010006 · Cited by 79
Self-citationKruzelock, R. P., Murphy, E. C., Strong, L. C., Naylor, S. L., & Hansen, M. F. (1997) · PubMed · Cited by 78
A comparative study between limb-salvage and amputation for treating osteosarcoma
Li, X., Zhang, Y. P., Wan, S., Li, H., Li, D., Xia, J., Yuan, Z., Ren, M., Yu, S., Li, S., et al. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.01.001 · Cited by 78
Fas expression inversely correlates with metastatic potential in osteosarcoma cells
Worth, L. L., Lafleur, E. A., Jia, S.-F., & Kleinerman, E. S. (2002) · Oncology Reports · doi:10.3892/or.9.4.823 · Cited by 77
Surgical management of adrenal metastases from lung cancer
Beitler, A. L., Urschel, J. D., Velagapudi, S., & Takita, H. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199809)69:1<21::aid-jso5>3.0.co;2-m · Cited by 75
Hingorani, P., Zhang, W., Gorlick, R. G., & Kolb, E. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1657 · Cited by 70
Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis
Chen, J., Sun, M., Hua, Y., & Cai, Z. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1644-0 · Cited by 69
MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R
Chen, G., Fang, T., Huang, Z., Qi, Y., Du, S., Di, T., Lei, Z., Zhang, X., & Yan, W. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438653 · Cited by 65
Luther, G. A., Lamplot, J. D., Chen, X., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.002 · Cited by 61
Prognosis of Osteosarcoma With Pulmonary Metastases at Initial Presentation Is Not Dismal
YONEMOTO, T., Tatezaki, S., Ishii, T., Satoh, T., Kimura, H., & Iwai, N. (1998) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199804000-00024 · Cited by 61
(2001) · PubMed · Cited by 61
Vásquez, L., Tarrillo, F., Oscanoa, M., Maza, I., Gerónimo, J., Paredes, G., Silva, J. M., & Sialer, L. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00022 · Cited by 61
Contrasting epidemiology of childhood osteosarcoma, Ewing's tumor, and rhabdomyosarcoma.
Miller, R. W. (1981) · PubMed · Cited by 60
Sex Differences in the Risks of Hormone-dependent Cancers
Silva, I. D. S., & Swerdlow, A. J. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116773 · Cited by 60
Bacci, G., Longhi, A., Bertoni, F., Briccoli, A., Versari, M., Pignotti, E., & Picci, P. (2006) · Acta Orthopaedica · doi:10.1080/17453670610013268 · Cited by 59
Gradl, G., Postl, L. K., Lenze, U., Stolberg-Stolberg, J., Pohlig, F., Rechl, H., Schmitt‐Sody, M., von Eisenhart‐Rothe, R., & Kirchhoff, C. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0721-0 · Cited by 58
Prognosis of Radiation-induced Bone Sarcoma is Similar to Primary Osteosarcoma
Shaheen, M. F., Deheshi, B. M., Riad, S., Werier, J. A., Holt, G. E., Ferguson, P. C., & Wunder, J. S. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000229315.58878.c1 · Cited by 57
Haddox, C. L., Han, G., Anijar, L., Binitie, O. T., Letson, G. D., Bui, M. M., & Reed, D. R. (2014) · Sarcoma · doi:10.1155/2014/402509 · Cited by 54
Poor Survival for Osteosarcoma of the Pelvis: A Report from the Children’s Oncology Group
Isakoff, M. S., Barkauskas, D. A., Ebb, D. H., Morris, C. D., & Letson, D. G. (2012) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-012-2284-9 · Cited by 52
Hagleitner, M. M., Coenen, M. J. H., Gelderblom, H. A. J., Makkinje, R. R., Vos, H. I., de Bont, E. S. J. M., van der Graaf, W. T. A., Schreuder, H. W. B., Flucke, U. E., van Leeuwen, F. N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2638 · Cited by 49
Radiotherapy in the Treatment of Primary Osteosarcoma – a Single Center Experience
Oertel, S., Blattmann, C., Rieken, S., Jensen, A., Combs, S. E., Huber, P. E., Bischof, M., Kulozik, A. E., Debus, J., & Schulz–Ertner, D. (2010) · Tumori Journal · doi:10.1177/030089161009600411 · Cited by 48
Pazopanib in metastatic osteosarcoma: Significant clinical response in three consecutive patients
Safwat, A., Boysen, A. K., Lücke, A. O., & Rossen, P. B. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.948062 · Cited by 47
Targeted therapies for bone sarcomas
Heymann, D., & Rédiní, F. (2013) · BoneKEy Reports · doi:10.1038/bonekey.2013.112 · Cited by 46
Kloen, P., Jennings, C. L., Gebhardt, M. C., Springfield, D. S., & Mankin, H. J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580323 · Cited by 44
Durnalı, A., Türköz, F. P., Yükrük, F. A., Tokluoğlu, S., Yazıcı, Ö. K., Demirci, A., Bal, Ö., Büyükbaş, S. G., Eşbah, O., Öksüzoğlu, B. Ç., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152621 · Cited by 43
Marais, L. C., Bertie, J., Rodseth, R. N., Sartorius, B. K. D., & Ferreira, N. (2015) · Journal of bone oncology · doi:10.1016/j.jbo.2015.09.002 · Cited by 39
Sarcoma in association with bone infarcts. Report of five cases.
Desai, P., Perino, G., Present, D., & Steiner, G. (1996) · PubMed · Cited by 37
Malignant tumors of the osteogenic matrix
Spina, V., Montanari, N., & Romagnoli, R. (1998) · European Journal of Radiology · doi:10.1016/s0720-048x(98)00050-3 · Cited by 36
Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray
Jentzsch, T., Robl, B., Husmann, M., Bode‐Lesniewska, B., & Fuchs, B. (2014) · PubMed · doi:10.5167/uzh-98588 · Cited by 32
Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma
Hattinger, C. M., & Serra, M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1060220 · Cited by 26
Palliative treatments for advanced osteosarcoma.
Mavrogenis, A. F., Rossi, G., Palmerini, E., Errani, C., Rimondi, E., Ruggieri, P., Soucacos, P. N., & Papagelopoulos, P. J. (2012) · PubMed · Cited by 16
Many faces of osteosarcoma on plain radiographs
Clayer, M. (2014) · ANZ Journal of Surgery · doi:10.1111/ans.12836 · Cited by 13
Wang, W., Wan, C., & Liao, G. (2015) · PubMed · Cited by 13
The WHO classification of bone tumors.
Sissons, H. A. (1976) · PubMed · doi:10.1007/978-3-642-80997-2_8
Cited by
Pan, S., Yin, J., Yu, L., Zhang, C., Zhu, Y., Gao, Y., & Chen, Y. (2020) · Advanced Science · doi:10.1002/advs.201901511 · Cited by 317
Genetically engineered pigs as models for human disease
Perleberg, C., Kind, A., & Schnieke, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.030783 · Cited by 222
Detection of circulating tumor DNA in patients with osteosarcoma
Barris, D. M., Weiner, S. B., Dubin, R. A., Fremed, M., Zhang, X., Piperdi, S., Zhang, W., Maqbool, S., Gill, J., Roth, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24268 · Cited by 63
Fu, Y., Xu, Y., Liu, W., Zhang, J., Wang, F., Jian, Q., Huang, G., Zou, C., Xie, X., Kim, A. H., et al. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102697 · Cited by 37
HIGUCHI, T., IGARASHI, K., YAMAMOTO, N., HAYASHI, K., KIMURA, H., MIWA, S., BOUVET, M., TSUCHIYA, H., & HOFFMAN, R. M. (2021) · Anticancer Research · doi:10.21873/anticanres.15406 · Cited by 25
Metadata
- Authors
- Durfee, R. A., Mohammed, M., & Luu, H. H.
- Venue
- Rheumatology and Therapy
- Published
- 2016-10-19
- Volume
- 3
- Issue
- 2
- Pages
- 221-243
- ISSN
- 2198-6576 (ISSN-L)
- 2198-6584
- OpenAlex
- W2536236658
- Cited by
- 395
- References
- 123
- FWCI
- 28.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.